Sustainability | September 12, 2023
JB Pharma publishes sustainability report for FY 2022-23
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
SÜDPACK customers also benefit when it comes to processing PharmaGuard
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Subscribe To Our Newsletter & Stay Updated
